Functional Class Helps Predict Mortality Risk after Surgery

Article ID: 636282

Released: 25-Jun-2015 11:45 AM EDT

Source Newsroom: International Anesthesia Research Society (IARS)

  • Share

Newswise — June 25, 2015 – Information on functional status—whether or not a person can carry out routine daily tasks independently—improves the ability to predict risk of death in patients undergoing surgery, according to a study in the July issue of Anesthesia & Analgesia.

Functional classification adds useful information on surgical mortality risk—beyond that provided by the routine American Society of Anesthesiologists (ASA) Physical Classification System, report Dr. Nader D. Nader and colleagues of University at Buffalo, N.Y. They write, "Functional classification was an independent predictor of mortality within each ASA class, indicating that it should be considered for incorporation into the routine preoperative evaluation."

Independent Functioning Predicts Better Surgical OutcomesThe study included more than 12,000 patients undergoing noncardiac surgery between 1998 and 2010, identified through a Veterans Affairs (VA) quality improvement database. Based on the widely used ASA functional classification, about 30 percent of patients were in ASA class II, with mild but well-controlled disease; 53 percent were in class III, denoting severe disease; 13 percent were in class IV, denoting severe, life-threatening disease; and one percent were in class V, including patients who are not expected to survive without surgery. (Another three percent of patients were in class I, denoting no health problems at all.) The researchers also rated each patient's functional status, based on their ability to perform routine activities of daily living (ADLs)—moving around, dressing, etc. Group A patients were completely independent in all ADLs, while group B patients were at least partially dependent on others. Not surprisingly, group B patients had more accompanying health problems, such as hypertension, diabetes, etc.

The results showed that patients who could perform all ADLs independently were at significantly lower risk of death. Short-term mortality rate was about two percent for group A patients versus 13 percent for those in group B.

In fact, group B patients in any ASA class were at higher risk of death than group A patients in the subsequent, sicker class. The odds of death were about 90 percent higher for group IIB patients versus IIIA patients, 30 percent higher for group IIIB versus IVA patients, and twice as high for group IVB versus group V patients.

After adjustment for other factors, group B patients were 4.5 times more likely to die within 30 days after surgery. Patients with any type of functional limitation were also at higher risk of complications, including myocardial infarction (heart attack), pneumonia, and reduced kidney function.

The ASA classification is a simple score for assessing preoperative health status, and is a reliable predictor of surgical mortality risk. However, in some groups of patients—such as the very elderly and those undergoing vascular surgery—the ASA system has limited value. That's because most of these patients are in ASA class III or IV and have multiple health problems.

Dr. Nader and coauthors write, "[A]dding functional capacity to traditional ASA classification improves its predictive value for short-term and long-term mortality and the occurrence of postoperative complications." They emphasize that even patients who appear "sicker" based on ASA class are at lower risk of death if they are functionally independent.

"Functional status assessment can be easily incorporated into the current ASA classification, as it can be assessed by patient interview alone and does not require any calculations, formulas, laboratory data, or diagnostic tests," Dr. Nader and colleagues add. One possible modification would be to increase the ASA class by one point for patients with any limitation in basic ADLs. However, the researchers emphasize the need for further studies in different patient populations.

Anesthesia & Analgesia is published by Wolters Kluwer.

Read the article in Anesthesia & Analgesia.


About Anesthesia & AnalgesiaAnesthesia & Analgesia was founded in 1922 and was issued bi-monthly until 1980, when it became a monthly publication. A&A is the leading journal for anesthesia clinicians and researchers and includes more than 500 articles annually in all areas related to anesthesia and analgesia, such as cardiovascular anesthesiology, patient safety, anesthetic pharmacology, and pain management. The journal is published on behalf of the IARS by Lippincott Williams & Wilkins (LWW), a division of Wolters Kluwer Health.

About the IARSThe International Anesthesia Research Society is a nonpolitical, not-for-profit medical society founded in 1922 to advance and support scientific research and education related to anesthesia, and to improve patient care through basic research. The IARS contributes nearly $1 million annually to fund anesthesia research; provides a forum for anesthesiology leaders to share information and ideas; maintains a worldwide membership of more than 15,000 physicians, physician residents, and others with doctoral degrees, as well as health professionals in anesthesia related practice; sponsors the SmartTots initiative in partnership with the FDA; supports the resident education initiative OpenAnesthesia; and publishes two journals, Anesthesia & Analgesia and A&A Case Reports.

About Wolters KluwerWolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer’s market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group serves customers in over 170 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on NYSE Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

For more information about our products and organization, visit, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.


Chat now!